Doylestown, Pennsylvania (PA) Research and Development Laboratories Companies
Featured companies
Not satisfied? Select a reason•Rate this page•Send feedback
Or try our search form or quick navigation by category and location
Clinical Mobilty Technology is a privately held company in Doylestown, PA and is a Unknown business.
Whereorg has 26 results under Research and Development Laboratories Companies in Doylestown, PA.
Other categories for location Bucks, Pennsylvania
All industries
Professional Services Commercial Physical and Biological Research Research and Development Laboratories
Other locations for category Research and Development Laboratories
Quick navigation
All industries
Professional Services
Commercial Physical and Biological Research
Research and Development Laboratories
Subcategory
City or suburb
- Bensalem8
- Bristol5
- Buckingham1
- Chalfont3
- Churchville1
- Croydon1
- Dublin2
- Erwinna1
- Fairless Hills2
- Feasterville Trevose2
- Feastervl Trvs5
- Holicong1
- Kintnersville1
- Langhorne9
- Levittown5
- Milford Square1
- Morrisville5
- New Britain1
- New Hope2
- Newtown21
- Perkasie5
- Pipersville5
- Plumsteadville1
- Quakertown4
- Richboro2
- Sellersville4
- Southampton6
- Spinnerstown2
- Trumbauersville1
- Tullytown1
- Upper Black Eddy1
- Warminster12
- Warrington5
- Wycombe1
- Yardley8
Top Stories
UBS flags buyback possibility after Second-quarter earnings beat
UBS , the world's largest wealth manager, on Tuesday signalled the possibility of resuming share buybacks later this year after generating more income than expected in the first six months and as it boosted...
Tue, Jul 21 2020
Greece calls EU recovery fund deal a 'national success'
Prime Minister Kyriakos Mitsotakis called a European Union deal on a post-pandemic recovery fund a "national success" that would allocate Greece around 72 billion euros ($82.38 billion) to help deal with...
Tue, Jul 21 2020
UBS second-quarter net profit dips as Swiss business dampens trading bonanza
UBS , the world's largest wealth manager, saw net profit drop 11% in the second quarter as higher trading activity failed to offset a pandemic-induced slump in retail and corporate banking.
Tue, Jul 21 2020